Some pharmaceutical companies now have teams that are dedicated to designing enzymes to make drugs more efficiently and with fewer toxic catalysts.
Einige Pharmaunternehmen haben nun eigene Abteilungen  zur Enzymentwicklung, um effektivere Medikamente mit weniger giftigen Katalysatoren zu machen.